Sugarloaf Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2
Closed -$179 715
2023
Q4
$179 Hold
2
﹤0.01% 664
2023
Q3
$146 Hold
2
﹤0.01% 665
2023
Q2
$166 Hold
2
﹤0.01% 672
2023
Q1
$152 Sell
2
-127
-98% -$10.5K ﹤0.01% 681
2022
Q4
$10.7K Buy
129
+1
+0.8% +$81 ﹤0.01% 488
2022
Q3
$11K Sell
128
-75
-37% -$6.32K ﹤0.01% 516
2022
Q2
$15K Buy
203
+176
+652% +$13.2K ﹤0.01% 463
2022
Q1
$2K Sell
27
-1
-4% -$92 ﹤0.01% 659
2021
Q4
$3K Hold
28
﹤0.01% 655
2021
Q3
$3K Hold
28
﹤0.01% 668
2021
Q2
$4K Buy
28
+1
+4% +$131 ﹤0.01% 633
2021
Q1
$4 Hold
27
﹤0.01% 621
2020
Q4
$4K Hold
27
﹤0.01% 584
2020
Q3
$3K Hold
27
﹤0.01% 595
2020
Q2
$3K Hold
27
﹤0.01% 588
2020
Q1
$2K Hold
27
﹤0.01% 622
2019
Q4
$3K Buy
+27
New +$2.33K ﹤0.01% 618

Other funds holding XBI